Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Novartis Restructures Pharma Division | Contract Pharma

What are you searching for?

Sign in
Breaking News

Novartis Restructures Pharma Division

Creates two business units—Novartis Pharmaceuticals and Novartis Oncology

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Novartis has restructured its Pharmaceuticals Division by creating two business units—Novartis Pharmaceuticals and Novartis Oncology. Both units will form the Innovative Medicines Division. Paul Hudson will be appointed chief executive officer, Novartis Pharmaceuticals, and Bruno Strigini will become chief executive officer, Novartis Oncology. Both will report directly to Joseph Jimenez, chief executive officer, Novartis. With these changes, David Epstein, currently division head and chief executive officer, Novartis Pharmaceuticals, has decided to leave the company.

Novartis said the new structure reflects the importance of oncology to the company following the integration of the oncology assets acquired from GSK.

From July 1, 2016 Novartis will continue to have three focused, customer-facing divisions: Innovative Medicines (formerly the Novartis Pharmaceuticals division), which will include the Novartis Pharmaceuticals and Novartis Oncology business units; Sandoz, the generics and biosimilar division, which includes the retail generics, anti-infectives and biopharmaceuticals franchises; and Alcon, the eye care devices division, which includes the surgical and vision care franchises.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters